The Manufacturers Life Insurance Company Sells 4,175 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

The Manufacturers Life Insurance Company reduced its holdings in Omega Healthcare Investors, Inc. (NYSE:OHI) by 1.7% in the 2nd quarter, Holdings Channel reports. The fund owned 239,464 shares of the real estate investment trust’s stock after selling 4,175 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Omega Healthcare Investors were worth $8,202,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Daiwa Securities Group Inc. increased its stake in Omega Healthcare Investors by 1,030.8% during the 2nd quarter. Daiwa Securities Group Inc. now owns 945,523 shares of the real estate investment trust’s stock worth $32,384,000 after purchasing an additional 861,907 shares in the last quarter. Marshall Wace LLP bought a new stake in shares of Omega Healthcare Investors during the second quarter worth $20,962,000. BROOKFIELD Corp ON acquired a new stake in shares of Omega Healthcare Investors during the first quarter worth $16,446,000. Verition Fund Management LLC lifted its position in Omega Healthcare Investors by 5,224.5% in the 4th quarter. Verition Fund Management LLC now owns 524,201 shares of the real estate investment trust’s stock valued at $16,072,000 after acquiring an additional 514,356 shares in the last quarter. Finally, Vanguard Group Inc. boosted its stake in Omega Healthcare Investors by 1.0% in the 4th quarter. Vanguard Group Inc. now owns 35,214,682 shares of the real estate investment trust’s stock worth $1,079,682,000 after purchasing an additional 346,811 shares during the period. Institutional investors and hedge funds own 65.25% of the company’s stock.

Analysts Set New Price Targets

OHI has been the topic of a number of research reports. Wells Fargo & Company restated an “overweight” rating and issued a $43.00 price target (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday. Truist Financial upped their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research report on Wednesday, September 4th. Mizuho downgraded shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and lifted their price objective for the company from $34.00 to $35.00 in a report on Thursday, July 25th. Finally, Scotiabank boosted their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research report on Monday, August 26th. Seven analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $36.00.

Insider Buying and Selling at Omega Healthcare Investors

In other news, CFO Robert O. Stephenson sold 22,542 shares of the business’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares in the company, valued at $7,357,824.44. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the transaction, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the sale, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.37% of the company’s stock.

Omega Healthcare Investors Trading Down 1.6 %

NYSE OHI opened at $39.34 on Friday. Omega Healthcare Investors, Inc. has a 12 month low of $27.53 and a 12 month high of $41.53. The company has a current ratio of 5.79, a quick ratio of 5.79 and a debt-to-equity ratio of 1.19. The stock has a 50 day moving average of $39.10 and a 200-day moving average of $34.61. The company has a market cap of $9.72 billion, a PE ratio of 35.44, a PEG ratio of 1.30 and a beta of 1.00.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings data on Thursday, August 1st. The real estate investment trust reported $0.45 EPS for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). The firm had revenue of $252.70 million during the quarter, compared to the consensus estimate of $205.92 million. Omega Healthcare Investors had a net margin of 33.52% and a return on equity of 8.61%. The business’s revenue was up 17.5% on a year-over-year basis. During the same period last year, the business earned $0.74 EPS. On average, equities research analysts anticipate that Omega Healthcare Investors, Inc. will post 2.69 EPS for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Monday, August 5th were paid a $0.67 dividend. The ex-dividend date was Monday, August 5th. This represents a $2.68 dividend on an annualized basis and a yield of 6.81%. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 241.44%.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.